A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : anti-VEGF

Search Conditions:
Search Keyword : anti-VEGF
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: anti-VEGF
Appearance Frequency: 808 time(s)
Long forms: 9

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
anti-vascular endothelial growth factor
(800 times)
Ophthalmology
(389 times)
AMD (124 times)
BCVA (106 times)
DME (95 times)
1996 Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy.
absolute benefits of vascular endothelial growth factor inhibitors
(1 time)
Medicine
(1 time)
AMD (1 time)
RR (1 time)
2016 Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
address the question of whether vascular endothelial growth factor inhibitors
(1 time)
Ophthalmology
(1 time)
DMO (1 time)
2011 Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review.
all patients received Vascular Endothelial Growth Factor
(1 time)
Ophthalmology
(1 time)
AMD (1 time)
rt-PA (1 time)
VA (1 time)
2011 Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
AMD patients receiving treatment with vascular endothelial growth factor inhibitors
(1 time)
Ophthalmology
(1 time)
AMD (1 time)
BCVA (1 time)
HRQoL (1 time)
2020 Predictors of health-related quality of life in Chinese patients receiving treatment for neovascular age-related macular degeneration: a prospective longitudinal study.
among the threeanti-vascular endothelial growth factor
(1 time)
Eye Diseases
(1 time)
AMD (1 time)
BEV (1 time)
BSR (1 time)
2021 Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation.
anti-endothelial vascular growth factor
(1 time)
Medicine
(1 time)
--- 2020 Treat and extend compared to pro re nata regimen in neovascular age-related macular degeneration.
anti-neovascular growth factor
(1 time)
Ophthalmology
(1 time)
AMD (1 time)
BCVA (1 time)
CNV (1 time)
2008 The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.
Antiangiogenic therapy with inhibitors of vascular endothelial growth factor
(1 time)
Ophthalmology
(1 time)
nAMD (1 time)
2021 [Ophthalmic safety profile of antiangiogenic therapy].